Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...

AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to ...

A musician who made global news as one of the first people to receive a skin cancer vaccine has held a sell-out concert to thank those who helped him. Steve Young, from Stevenage, Hertfordshire, ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, discusses what she is most looking forward to in the future of brain ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.

Attorneys general from 22 states filed a lawsuit Monday against the Trump administration for slashing funding for medical and ...

Universities that do breakthrough-level studies are scrambling to understand the effects as their funding agencies slash ...

The lawsuit, filed in federal court in Boston, challenges the Trump administration, the Department of Health and Human ...

And if we use senolytics, we see that the inflammation goes away and the regenerative capacity of the surrounding tissue is restored — well, at least if you’re a mouse.” Based on dozens of preclinical ...

Attorneys general from 22 states, including Wisconsin, filed a lawsuit against the Trump administration for cutting funding ...